Scientific Due Diligence
A strong commercial story can become much harder to defend when an outside party starts asking detailed questions about the science behind the product, formulation, claims, or evidence.
Fowoyo Scientific Consulting examines the scientific story as an outside reviewer might, looking for weaknesses, inconsistencies, evidence gaps, formulation concerns, and questions that could surface during external review.
This Service May Be a Fit If
We Examine the Scientific Story the Way an Outside Reviewer Might
The purpose is not to make the company look perfect. It is to identify what could weaken the scientific story, understand how important each issue is, and decide what should be addressed before outside scrutiny begins.
Scientific Due Diligence Readiness Report
You receive an independent review of the scientific vulnerabilities that could be raised during external scrutiny.
The report prioritizes the issues and provides recommended corrective actions so you can decide what should be fixed, documented, investigated, or prepared for before the other side begins asking questions.
Red flags
Scientific issues that could materially weaken the story being presented.
Weak or unsupported claims
Claims that may be difficult to defend against the available evidence.
Ingredient and formulation evidence gaps
Questions about whether the scientific record adequately supports the ingredients, forms, doses, or intended product benefits.
Documentation gaps
Missing or incomplete scientific records that may become important during review.
Scientific inconsistencies
Places where claims, evidence, product information, or scientific materials do not tell the same story.
Outside-reviewer questions
Difficult scientific questions an investor, acquirer, retailer, buyer, partner, or other reviewer may raise.
Recommended corrective actions
Practical steps to address, document, investigate, or prepare for identified issues.
Issue priorities
A clear indication of which findings deserve the most immediate attention.
Preparing Your Company or Evaluating Another One
Company-Side Readiness
For companies preparing for investor, acquirer, retailer, buyer, partner, or other external scrutiny. FSC identifies vulnerabilities before the outside review so the company can prepare and address important issues.
Investor or Acquirer-Side Evaluation
For a party considering a transaction, FSC can independently evaluate the target's scientific story, evidence, formulation, claims, and identified gaps. This engagement may be delivered as an Independent Scientific Due Diligence Report.
Do Not Let the Other Side Discover the Problem First
Late scientific surprises
Important weaknesses appearing only after external review has already begun.
Loss of confidence
Outside parties questioning the broader scientific story because important gaps were not identified early.
Negotiation problems
Scientific weaknesses becoming leverage for the other side during a high-stakes discussion.
Unprepared answers
Leadership being surprised by questions that could have been anticipated beforehand.
Preventable delays
Documentation or evidence issues slowing a review because they were discovered too late.
Review the Science Before the Stakes Get Higher
Before fundraising
When investors may examine the scientific basis behind the product or company story.
Before acquisition or partnership discussions
When scientific weaknesses could surface during a transaction or strategic review.
Before retailer or buyer review
When an outside commercial party may scrutinize claims, evidence, ingredients, or documentation.
When evaluating a target
When an investor or acquirer needs an independent scientific assessment before making a decision.
Facing Outside Scrutiny?
Tell us what review, transaction, retailer discussion, investment decision, or other external scrutiny you are preparing for.
We will determine the scope of the scientific review and whether Scientific Due Diligence is the right service for the situation.
Schedule a Consultation →